Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Transplant. 2015 Dec 10;16(3):833–840. doi: 10.1111/ajt.13525

Table 1.

Demographic data

Stage 1 Stage 2

Variable PGD (n=79) No PGD (n=218) P value PGD (n=225) No PGD (n=503) P value
Donor
 Age 32.7±14.0 32.3±13.7 0.836 35.0±13.8 34.9±14.4 0.906
 IT(min) 283.2±85.5 284.5±88.3 0.914 334.0±94.4 328.4±106.8 0.483
Recipient
 Age 52.7±10.1 53.7±11.6 0.511 52.7±12.6 53.4±13.4 0.490
 Female 36(45.6%) 103(47.3%) 0.798 102(45.3%) 212(42.2%) 0.422
Diagnosis <0.001 <0.001
  COPD 26(32.9%) 122(56.0%) 62(27.6%) 188(37.4%)
  CF   3(3.8%) 25(11.5%) 23(10.2%)   86(17.1%)
  IPF 37(46.8%) 61(28.0%) 94(41.8%) 185(36.8%)
  IPAH   4(5.6%)   4(1.8%)   9(4.0%)   11(2.2%)
  Sarcoid   5(6.3%)   1(0.5%) 14(6.2%)   12(2.4%)
  Other   4(5.1%)   5(2.3%) 23(10.2%)   21(4.2%)
 BLTX 44(55.7%) 121(55.5%) 0.977 155(68.9%) 346(68.8%) 0.978
 CPB 46(42.9%) 50(26.3%) 0.003 127(52.5%) 152(31.3%) <0.001

Abbreviations: IT, total ischemic time(time when last clamp removed); COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; IPAH, idiopathic pulmonary arterial hypertension; BLTX, bilateral lung transplant; CPB, cardiopulmonary bypass.

Data are expressed as mean ± SD, unless otherwise stated. Percent are numerators divided by the total number of subjects with PGD or without PGD with complete data. The reported P value results from unpaired t test or chi squared as appropriate.